{
    "medicine_id": "420fc312b69362be4b061c2788993d0a9b966711",
    "platform_id": "DB11239",
    "metadata": {
        "name": "Aluminum Acetate Astringent 36 45 mg Powder",
        "composition": "36 45 mg Aluminum sulfate",
        "clinical_particulars": {
            "therapeutic_indications": "Solutions containing 5 to 10 aluminum sulfate have been used as local applications to ulcers and to arrest foul discharges from mucous surfaces Aluminum sulfate is also used in the preparation of aluminum acetate ear drops L2149 It is often purchased over the counter and is available in solid stick or powder form for minor cuts and abrasions after shaving L2157 L2164 Aluminum sulfate is also used as an adjuvant in vaccines L2158",
            "contraindications": {
                "disease": "Aluminum Sulfate Hydrated ACS FCC ORAL LD50 Acute 9000 mg kg in the ouse MSDS 9000 mg kg in the rat MSDS Acute Toxicity There is little indication that aluminum is acutely toxic by oral exposure despite it is widely found in foods drinking water and many antacid preparations L2149 In 1988 a population of about 20 000 citizens of Camelford England was exposed to increased levels of aluminum for 5 days The aluminum was accidentally ingested by the population from a water supply facility using aluminum sulfate for water treatment L2149 Some adverse effects observed were nausea vomiting diarrhea mouth ulcers skin ulcers skin rashes and arthritis type pain were observed It was concluded in one study that the adverse effects of aluminum sulfate were primarily mild and transient No long lasting effects on health could be attributed to the exposures from aluminum in the drinking water during this period L2149 Chronic Toxicity In humans excess exposure to aluminum via dialysis water aluminum sulfate is a known etiological factor in several pathological conditions in patients treated with hemodialysis Clinical symptoms and signs of aluminum toxicity include hypercalcemia anemia vitamin D refractory osteodystrophy and a dialysis encephalopathy Bone pain pathological fractures and proximal myopathy may occur Aluminum has also been suggested as an etiology of several neurodegenerative diseases such as Alzheimer senile and pre senile dementia as well amyotrophic sclerosis Despite this the most recent investigations have failed to confirm this hypothesis A study in man has verified a number of possible deleterious interactions of aluminum salts with phosphorous metabolism especially in long term ingestion of aluminum containing antacids L2152 It has been suggested that aluminum exposure is a risk factor for the development or acceleration of onset of Alzheimer disease AD in humans The world health organization has completed a meta analysis of 20 epidemiological studies done to test the hypothesis that aluminum in drinking water is a risk factor for Alzheimer disease Six studies on populations in Norway were considered of sufficiently high quality to meet the general criteria for exposure and outcome assessment and the adjustment for at least some confounding variables L2149 Of six studies that examined the relationship between aluminum in drinking water and dementia three found a positive relationship but three did not However each of the studies had significant deficiencies in the study design e g ecological exposure assessment failure to consider aluminum exposure from all sources and to control for important confounders such as education socioeconomic status and family history the use of surrogate outcome measures for AD and selection bias L2149 In general the relative risks determined were less than 2 with large confidence intervals when the total aluminum concentration in drinking water was 0 1 mg L or higher Due to the pathogenesis of AD and knowledge obtained from studies it was concluded that the present epidemiological evidence does not support a causal association between AD and aluminum in drinking water L2149 In addition to the epidemiological studies that examined the relationship between AD and aluminum in drinking water two studies studied cognitive dysfunction in elderly populations in relation to the levels of aluminum in drinking water The results proved conflicting A study of 800 male subjects age 80 89 drinking water containing aluminum concentrations up to 98 \u03bcg L found no relationship The second study used any evidence of mental impairment as an outcome measure and found a relative risk of 1 72 at aluminum drinking water concentrations above 85 \u03bcg L in 250 males Such data are insufficient to show that aluminum is a cause of cognitive impairment in the elderly L2149 Note on possible risk of breast cancer Widespread concern has been raised regarding the exposure to aluminum in deodorant antiperspirant products with inconclusive results L2165 L2167 L2168 L2169 Results from a more recent case control study suggest an association between underarm cosmetic use and aluminum concentration in breast tissue and breast cancer The observed association of underarm cosmetic use with breast cancer was however limited to women who report using the products multiple times a day before age of 30 A32464",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Aluminum sulfate may be used as a deodorant as well as an astringent L2160 Aluminum sulfate is also known as an astringent Astringents are substances that cause contraction or shrinkage of tissues and that dry up secretion L2160 Used as a post shaving treatment it can eliminate bleeding from superficial wounds L2157 L2164 It has also shown in vitro anti microbial activity L2160",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06210",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The serum concentration of Glycochenodeoxycholic Acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The serum concentration of Cholic Acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The serum concentration of Glycocholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The serum concentration of Deoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The serum concentration of Taurocholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The serum concentration of Obeticholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The serum concentration of Bamet UD2 can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB08858",
                        "description": "The serum concentration of cis Diamminechlorocholylglycinateplatinum II can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The serum concentration of Dehydrocholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The serum concentration of Hyodeoxycholic Acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB11860",
                        "description": "The serum concentration of Aramchol can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB14016",
                        "description": "The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "The serum concentration of Technetium Tc 99m oxidronate can be increased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}